TXMD
TherapeuticsMD Inc
NASDAQ: TXMD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.04
-3.32% today
Updated 2026-04-30
Market cap
$24.31M
P/E ratio
—
P/S ratio
8.04x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+6.5
Quality
B2.0
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-33.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$5.00
+145.10%
12-Month target
$0.07
-96.57%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $1.37M — positive
+ Revenue growth 33.90% QoQ
+ Debt/equity 0.24x — low leverage
Risks
- Altman Z -33.02 — distress zone
- Thin margins at -18.80%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $69.96M | $1.30M | $1.76M | $3.02M | $3.02M |
| Net income | $112.00M | $-10.28M | $-2.18M | $-569000.00 | $-619000.00 |
| EPS | — | — | — | — | $-0.06 |
| Free cash flow | $-4.43M | $-96.28M | $732000.00 | $2.45M | $1.37M |
| Profit margin | 160.08% | -789.40% | -123.85% | -18.83% | -18.80% |
Peer comparison
Smart narrative
TherapeuticsMD Inc trades at $2.04. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -33.02, it sits in the distress. TTM revenue stands at $3.02M. with profit margins at -18.80%.
Frequently asked questions
What is TherapeuticsMD Inc's stock price?
TherapeuticsMD Inc (TXMD) trades at $2.04.
Is TherapeuticsMD Inc overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell).
What is the price target of TherapeuticsMD Inc (TXMD)?
The analyst target price is $5.00, representing +145.1% upside from the current price of $2.04.
What is TherapeuticsMD Inc's revenue?
TTM revenue is $3.02M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-33.02 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio8.04x
ROE-2.41%
Beta0.56
50D MA$2.18
200D MA$1.66
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—